Literature DB >> 1951350

The United States Renal Data System's 1991 annual data report: an introduction.

P J Held, F K Port, R L Webb, R A Wolfe, J R Garcia, C R Blagg, L Y Agodoa.   

Abstract

Mesh：

Year:  1991        PMID： 1951350

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  15 in total

1.  Metabolic reprogramming by N-acetyl-seryl-aspartyl-lysyl-proline protects against diabetic kidney disease.

Authors:  Swayam Prakash Srivastava; Julie E Goodwin; Keizo Kanasaki; Daisuke Koya
Journal:  Br J Pharmacol       Date:  2020-06-22       Impact factor: 8.739

2.  The role of vascular endothelial growth factor +405 G/C polymorphism and albuminuria in patients with type 2 diabetes mellitus.

Authors:  Abdolrahim Nikzamir; Alireza Esteghamati; Amir Abbas Hammedian; Touraj Mahmoudi
Journal:  Mol Biol Rep       Date:  2011-05-12       Impact factor: 2.316

3.  Association of vascular endothelial growth factor -634G/C and receptor for advanced glycation end products G82S gene polymorphisms with diabetic retinopathy.

Authors:  Asmaa Kamal; Khaled Abu Eleinen; Ibrahem Siam
Journal:  Int J Ophthalmol       Date:  2016-08-18       Impact factor: 1.779

4.  FVB mouse genotype confers susceptibility to OVE26 diabetic albuminuria.

Authors:  Jianxiang Xu; Yun Huang; Fenge Li; Shirong Zheng; Paul N Epstein
Journal:  Am J Physiol Renal Physiol       Date:  2010-07-07

5.  Chronic administration of EP4-selective agonist exacerbates albuminuria and fibrosis of the kidney in streptozotocin-induced diabetic mice through IL-6.

Authors:  Riyaz Mohamed; Calpurnia Jayakumar; Ganesan Ramesh
Journal:  Lab Invest       Date:  2013-07-01       Impact factor: 5.662

6.  An association between vascular endothelial growth factor gene promoter polymorphisms and diabetic retinopathy.

Authors:  Jacek P Szaflik; Tomasz Wysocki; Michal Kowalski; Ireneusz Majsterek; Anna I Borucka; Janusz Blasiak; Jerzy Szaflik
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-09-12       Impact factor: 3.117

7.  What the radiologist needs to know about the diabetic patient.

Authors:  Athanasios E Raptis; Konstantinos P Markakis; Maria C Mazioti; Sotirios A Raptis; George D Dimitriadis
Journal:  Insights Imaging       Date:  2011-02-02

8.  Emerging therapies for diabetic nephropathy patients: beyond blockade of the Renin-Angiotensin system.

Authors:  Bassem Y Tanios; Fuad N Ziyadeh
Journal:  Nephron Extra       Date:  2012-10-30

9.  Renal kallikrein activation and renoprotection after dual blockade of renin-angiotensin system in diet-induced diabetic nephropathy.

Authors:  Xia Zou; Xiao-xi Zhang; Xin-yu Liu; Rong Li; Min Wang; Wei-jie Wu; Yi Sui; Hai-lu Zhao
Journal:  J Diabetes Res       Date:  2015-03-30       Impact factor: 4.011

10.  Effects of Brown Seaweed (Sargassum polycystum) Extracts on Kidney, Liver, and Pancreas of Type 2 Diabetic Rat Model.

Authors:  Mahsa Motshakeri; Mahdi Ebrahimi; Yong Meng Goh; Hemn Hassan Othman; Mohd Hair-Bejo; Suhaila Mohamed
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-08       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.